PremiumRatingsMorgan Stanley’s Graham Parry Reiterates Buy on Novartis, Citing Pelacarsen Upside and Above‑Consensus EPS Outlook3d agoNVS
Morgan Stanley’s Graham Parry Reiterates Buy on Novartis, Citing Pelacarsen Upside and Above‑Consensus EPS Outlook